Assessment of the immune interference effects of multivalent vaccine for influenza epidemic strain in 2022–2023 and evaluation of its efficacy
The various strains of influenza virus cause respiratory symptoms in humans every year and annual vaccinations are recommended. Due to its RNA-type genes and segmented state, it belongs to a virus that mutates frequently with antigenic drift and shift, giving rise to various strains. Each year, the...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-03-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024043573 |
| _version_ | 1797224102731186176 |
|---|---|
| author | Eulhae Ga Jung-Ah Kang Jaehyun Hwang Suyun Moon Jaeseok Choi Eunseo Bae Hyein Seol Yubin Mun Daesub Song Dae Gwin Jeong Woonsung Na |
| author_facet | Eulhae Ga Jung-Ah Kang Jaehyun Hwang Suyun Moon Jaeseok Choi Eunseo Bae Hyein Seol Yubin Mun Daesub Song Dae Gwin Jeong Woonsung Na |
| author_sort | Eulhae Ga |
| collection | DOAJ |
| description | The various strains of influenza virus cause respiratory symptoms in humans every year and annual vaccinations are recommended. Due to its RNA-type genes and segmented state, it belongs to a virus that mutates frequently with antigenic drift and shift, giving rise to various strains. Each year, the World Health Organization identifies the epidemic strains and operates a global surveillance system to suggest the viral composition for the influenza vaccine. Influenza viruses, which have multiple viral strains, are produced in the format of multivalent vaccine. However, the multivalent vaccine has a possibility of causing immune interference by introducing multiple strain-specific antigens in a single injection. Therefore, evaluating immune interference phenomena is essential when assessing multivalent vaccines. In this study, the protective ability and immunogenicity of multivalent and monovalent vaccines were evaluated in mice to assess immune interference in the multivalent vaccine. Monovalent and multivalent vaccines were manufactured using the latest strain of the 2022–2023 seasonal influenza virus selected by the World Health Organization. The protective abilities of both types of vaccines were tested through hemagglutination inhibition test. The immunogenicity of multivalent and monovalent vaccines were tested through enzyme-linked immunosorbent assay to measure the cellular and humoral immunity expression rates. As a result of the protective ability and immunogenicity test, higher level of virus neutralizing ability and greater amount of antibodies in both IgG1 and IgG2 were confirmed in the multivalent vaccine. No immune interference was found to affect the protective capacity and immune responses of the multivalent vaccines. |
| first_indexed | 2024-04-24T13:47:47Z |
| format | Article |
| id | doaj.art-006caf6227f24dbba958c26cf513c105 |
| institution | Directory Open Access Journal |
| issn | 2405-8440 |
| language | English |
| last_indexed | 2024-04-24T13:47:47Z |
| publishDate | 2024-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Heliyon |
| spelling | doaj.art-006caf6227f24dbba958c26cf513c1052024-04-04T05:07:11ZengElsevierHeliyon2405-84402024-03-01106e28326Assessment of the immune interference effects of multivalent vaccine for influenza epidemic strain in 2022–2023 and evaluation of its efficacyEulhae Ga0Jung-Ah Kang1Jaehyun Hwang2Suyun Moon3Jaeseok Choi4Eunseo Bae5Hyein Seol6Yubin Mun7Daesub Song8Dae Gwin Jeong9Woonsung Na10College of Veterinary Medicine, Chonnam National University, Gwangju, 61186, South Korea; College of Veterinary Medicine and BK21 FOUR Program, Chonnam National University, Gwangju, 61186, South KoreaBionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, South KoreaCollege of Veterinary Medicine, Chonnam National University, Gwangju, 61186, South Korea; College of Veterinary Medicine and BK21 FOUR Program, Chonnam National University, Gwangju, 61186, South KoreaCollege of Veterinary Medicine, Chonnam National University, Gwangju, 61186, South Korea; College of Veterinary Medicine and BK21 FOUR Program, Chonnam National University, Gwangju, 61186, South KoreaCollege of Veterinary Medicine, Chonnam National University, Gwangju, 61186, South Korea; College of Veterinary Medicine and BK21 FOUR Program, Chonnam National University, Gwangju, 61186, South KoreaCollege of Veterinary Medicine, Chonnam National University, Gwangju, 61186, South Korea; College of Veterinary Medicine and BK21 FOUR Program, Chonnam National University, Gwangju, 61186, South KoreaBionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, South KoreaBionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, South KoreaCollege of Veterinary Medicine, Seoul National University, Gwanak-ro, Seoul, 08826, South KoreaBionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, South Korea; Corresponding author.Department of Oral Microbiology and Immunology and Dental Research Institute, School of Dentistry, Seoul National University, Daehak-ro 101 (Yeongeon-dong), Jongno-gu, Seoul, 03080, South Korea; Corresponding author.The various strains of influenza virus cause respiratory symptoms in humans every year and annual vaccinations are recommended. Due to its RNA-type genes and segmented state, it belongs to a virus that mutates frequently with antigenic drift and shift, giving rise to various strains. Each year, the World Health Organization identifies the epidemic strains and operates a global surveillance system to suggest the viral composition for the influenza vaccine. Influenza viruses, which have multiple viral strains, are produced in the format of multivalent vaccine. However, the multivalent vaccine has a possibility of causing immune interference by introducing multiple strain-specific antigens in a single injection. Therefore, evaluating immune interference phenomena is essential when assessing multivalent vaccines. In this study, the protective ability and immunogenicity of multivalent and monovalent vaccines were evaluated in mice to assess immune interference in the multivalent vaccine. Monovalent and multivalent vaccines were manufactured using the latest strain of the 2022–2023 seasonal influenza virus selected by the World Health Organization. The protective abilities of both types of vaccines were tested through hemagglutination inhibition test. The immunogenicity of multivalent and monovalent vaccines were tested through enzyme-linked immunosorbent assay to measure the cellular and humoral immunity expression rates. As a result of the protective ability and immunogenicity test, higher level of virus neutralizing ability and greater amount of antibodies in both IgG1 and IgG2 were confirmed in the multivalent vaccine. No immune interference was found to affect the protective capacity and immune responses of the multivalent vaccines.http://www.sciencedirect.com/science/article/pii/S2405844024043573Multivalent vaccineInfluenza virusSeasonal fluImmune interferenceVaccine immunology |
| spellingShingle | Eulhae Ga Jung-Ah Kang Jaehyun Hwang Suyun Moon Jaeseok Choi Eunseo Bae Hyein Seol Yubin Mun Daesub Song Dae Gwin Jeong Woonsung Na Assessment of the immune interference effects of multivalent vaccine for influenza epidemic strain in 2022–2023 and evaluation of its efficacy Heliyon Multivalent vaccine Influenza virus Seasonal flu Immune interference Vaccine immunology |
| title | Assessment of the immune interference effects of multivalent vaccine for influenza epidemic strain in 2022–2023 and evaluation of its efficacy |
| title_full | Assessment of the immune interference effects of multivalent vaccine for influenza epidemic strain in 2022–2023 and evaluation of its efficacy |
| title_fullStr | Assessment of the immune interference effects of multivalent vaccine for influenza epidemic strain in 2022–2023 and evaluation of its efficacy |
| title_full_unstemmed | Assessment of the immune interference effects of multivalent vaccine for influenza epidemic strain in 2022–2023 and evaluation of its efficacy |
| title_short | Assessment of the immune interference effects of multivalent vaccine for influenza epidemic strain in 2022–2023 and evaluation of its efficacy |
| title_sort | assessment of the immune interference effects of multivalent vaccine for influenza epidemic strain in 2022 2023 and evaluation of its efficacy |
| topic | Multivalent vaccine Influenza virus Seasonal flu Immune interference Vaccine immunology |
| url | http://www.sciencedirect.com/science/article/pii/S2405844024043573 |
| work_keys_str_mv | AT eulhaega assessmentoftheimmuneinterferenceeffectsofmultivalentvaccineforinfluenzaepidemicstrainin20222023andevaluationofitsefficacy AT jungahkang assessmentoftheimmuneinterferenceeffectsofmultivalentvaccineforinfluenzaepidemicstrainin20222023andevaluationofitsefficacy AT jaehyunhwang assessmentoftheimmuneinterferenceeffectsofmultivalentvaccineforinfluenzaepidemicstrainin20222023andevaluationofitsefficacy AT suyunmoon assessmentoftheimmuneinterferenceeffectsofmultivalentvaccineforinfluenzaepidemicstrainin20222023andevaluationofitsefficacy AT jaeseokchoi assessmentoftheimmuneinterferenceeffectsofmultivalentvaccineforinfluenzaepidemicstrainin20222023andevaluationofitsefficacy AT eunseobae assessmentoftheimmuneinterferenceeffectsofmultivalentvaccineforinfluenzaepidemicstrainin20222023andevaluationofitsefficacy AT hyeinseol assessmentoftheimmuneinterferenceeffectsofmultivalentvaccineforinfluenzaepidemicstrainin20222023andevaluationofitsefficacy AT yubinmun assessmentoftheimmuneinterferenceeffectsofmultivalentvaccineforinfluenzaepidemicstrainin20222023andevaluationofitsefficacy AT daesubsong assessmentoftheimmuneinterferenceeffectsofmultivalentvaccineforinfluenzaepidemicstrainin20222023andevaluationofitsefficacy AT daegwinjeong assessmentoftheimmuneinterferenceeffectsofmultivalentvaccineforinfluenzaepidemicstrainin20222023andevaluationofitsefficacy AT woonsungna assessmentoftheimmuneinterferenceeffectsofmultivalentvaccineforinfluenzaepidemicstrainin20222023andevaluationofitsefficacy |